← Back to all signals
RESEARCH PAPER ANALYSIS

Identity among adolescent and young adult cancer survivors: an exploratory qualitative study.

A secondary grounded-theory analysis of six focus groups found that physical, psychological, and social changes shape identity among AYA cancer survivors, with sexual and gender minority survivors additionally reporting heteronormative assumptions and disclosure challenges in healthcare.

Open original publication →
PMID42681105
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Publication Date2026-09-02
Ingested2026-09-04 09:15 AM
EXECUTIVE SUMMARY

What the AI sees

A secondary grounded-theory analysis of six focus groups found that physical, psychological, and social changes shape identity among AYA cancer survivors, with sexual and gender minority survivors additionally reporting heteronormative assumptions and disclosure challenges in healthcare.

WHY IT MATTERS

Research significance

The study provides qualitative evidence of identity-related and SGM-specific supportive-care needs; it is reasonable—but not tested here—to hypothesize that tailored psychological interventions, peer support, and more inclusive clinical practices could improve psychosocial outcomes.

ABSTRACT

Source abstract

PURPOSE: Research on the implications of cancer on identity formation in adolescent and young adult (AYA) survivors is limited, particularly for sexual and gender minority (SGM) AYA cancer survivors. The aims of this study were to (1) identify concepts related to the impact of cancer and its treatment on identity among AYAs (ages of 15-39) cancer survivors; and (2) explore the unique identity-related experiences of sexual and gender minority (SGM) AYA cancer survivors. METHODS: This is a secondary qualitative analysis of six focus groups conducted during the development of an AYA program. Transcripts were coded using a grounded theory approach to identify how cancer diagnosis and treatment shape AYA identity formation, which informed the development of a novel conceptual framework. RESULTS: AYA cancer survivors' identity is influenced by interrelated physical, psychological, and social changes. Surrounding these interrelated changes are experiences unique to SGM, including navigating heteronormative assumptions and disclosures within healthcare settings. These interrelated changes to identity contribute to an evolution of the self through the cancer trajectory. CONCLUSION: Our findings deepen the literature on the need for clinician awareness of how cancer diagnosis and treatment shapes AYA identities, and the need for increased support for AYAs (e.g., psychological intervention, peer support groups). From a public health perspective, this analysis contributes new insight into SGM AYA cancer survivors, as they may have a cancer experience that differs from that of their heterosexual peers. Further research to understand the needs of this population is warranted.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Prevalence and Associations for Use of Complementary and Alternative Medicine (CAM) Among Paediatric Cancer Patients in Norway: A Cross-Sectional Survey. Integrative cancer therapies 69.0 2 Portal cavernoma: epidemiological, clinical, etiological and outcome profiles - a 15-year retrospective study in a University Hospital in Rabat, Morocco. The Pan African medical journal 63.5 3 Artificial intelligence in Vietnamese healthcare: public awareness, demand, and willingness to pay. BMC health services research 60.2 4 Xp11.2 Translocation Renal Cell Carcinoma in an Elderly Woman: A Diagnostic Challenge - A Case Report. Case reports in oncology 49.0 5 The unbalanced needs and perceived supply of supportive care in family caregivers of patients with multiple myeloma: a cross-sectional study. BMC palliative care 59.9 6 Development and Optimization of 111 In-Dinutuximab-IRDye800, a Dual-Modality Intraoperative Molecular Imaging Agent for Pediatric Neuroblastoma Resection. bioRxiv : the preprint server for biology 77.4 7 High-Resolution Subtyping of Pediatric Low-Grade Glioma Using an Integrated Meta-Clustering Framework. bioRxiv : the preprint server for biology 67.5 8 Concordance of rapid whole genome and targeted long read sequencing of pediatric brain tumors with standard clinical testing. Research square 61.9 9 Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit. bioRxiv : the preprint server for biology 57.6 10 Clinical Presentation of, Treatment Approaches for, and the Impact of Social Determinants of Health on Pediatric Catatonia: A Structured Qualitative Synthesis and Targeted Literature Review. Cureus 66.04 11 Sequential Philadelphia-Positive Pre-B Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia With Distinct BCR::ABL1 Fusion Transcripts. Cancer reports (Hoboken, N.J.) 67.1 12 Intracranial germ cell tumours presenting with AVP deficiency and evolving panhypopituitarism: diagnostic pitfalls in early imaging and biopsy. Endocrinology, diabetes & metabolism case reports 64.0 13 A Subset of FOXO1-Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and "Burkitt-Like" Morphology Is Associated With High Amplification of MYCL: A Report From the Children's Oncology Group. Genes, chromosomes & cancer 57.5 14 Pediatric lynch-associated melanoma arising in ovarian teratoma: a case report. Gynecologic oncology reports 55.1 15 Case Report: Case series: growth hormone replacement for severe growth hormone deficiency during BRAF inhibitor therapy in pediatric low-grade glioma: long-term follow-up. Frontiers in endocrinology 70.3 16 Prognostic value of lymph node ratio in children with wilms tumor: a systematic review and meta-analysis. Frontiers in oncology 79.6 17 Real-world efficacy and safety of efgartigimod in patients with autoimmune encephalitis: a single-center retrospective analysiss. Frontiers in immunology 69.1 18 Combined aromatherapy and music or sound for emotional distress: a systematic review of controlled studies published between 2019 and 2026. Frontiers in psychology 84.84 19 Longitudinal follow-up of autoimmune neutropenia in adults-a single-cohort experience. Frontiers in immunology 69.8 20 A spectrum of tumorigenesis in an IDH1-mosaic patient with Ollier disease, acute myeloid leukaemia, and parathyroid adenoma. Frontiers in genetics 57.0 21 From armed-conflict to care: clinical outcomes, diagnostic challenges, and psychosocial burden in children evaluated for suspected cancer displaced from Gaza and treated at a regional center of excellence. Frontiers in oncology 68.2 22 Clinical and radiological features of posterior reversible encephalopathy syndrome in children: a retrospective study. Frontiers in pediatrics 69.3 23 Case Report: Cytomegalovirus-associated granulomatous lung disease in an immunocompetent preterm infant. Frontiers in immunology 47.5 24 Atypical echocardiographic phenotype of end-stage hypertrophic cardiomyopathy: a case series. Frontiers in cardiovascular medicine 57.0 25 Utilizing BRAF/MEK Inhibitors to Reduce Morbidity in a Pediatric Patient With Ameloblastoma: A Case Report. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons 55.26 26 EWSR1-FLI1 expression combined with monoallelic EWSR1 depletion is associated with mitotic spindle damage and nocodazole sensitivity. Biology open 53.3 27 Real-World Outcomes of Total Body Irradiation versus Chemotherapy-Based Conditioning in Pediatric Acute Lymphoblastic Leukemia. Clinical epidemiology 74.84 28 Structure and Function of Archaeal SRP54 Protein Mutants Associated with Human Severe Congenital Neutropenia. ACS omega 55.0 29 Minibeam Radiotherapy in Pediatric Cancer: First Clinical Use in a Treatment-Refractory Sarcoma. Pediatric blood & cancer 58.3 30 Refractory Idiopathic Infantile Pyoderma Gangrenosum Successfully Treated With Infliximab: A Case Report. Case reports in pediatrics 61.72 31 Prospective evaluation of serum methotrexate pharmacokinetics following intrathecal methotrexate in acute lymphoblastic leukaemia. British journal of haematology 62.8 32 Gradient-driven microfluidic framework for the screening of ratiometric drug combinations towards precision oncology in paediatric leukaemia. Nature biomedical engineering 64.16
PATIENT-FRIENDLY SUMMARY

Identity among adolescent and young adult cancer survivors: an exploratory qualitative study.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic